Effects of temperature, pH, and inhibitors on the procoagulant characterization of FIa, a factor X activator from the venom of Daboia russellii siamensis (Myanmar)
- 101 Downloads
- 1 Citations
Abstract
FIa, a factor X activator, was isolated from the venom of Daboia russellii siamensis (Myanmar) after a series of chromatographic separations. FIa displayed procoagulant activity by shortening plasma recalcification time and converted human factor X (FX) to activated human factor X (FXa) by cleaving the heavy FX chain, possibly at the Arg51-Ile52 peptide. FIa was positive in a glycoprotein staining test, demonstrating that it is a glycoprotein. Optimal temperature and pH values were important for FIa procoagulant activity. Procoagulant activity was maintained above 85% of the initial activity at pH 7.0∼8.0, and showed equally maximum activity at temperatures ranging from 30 to 50°C. In addition, FIa procoagulant activity was completely inhibited by EDTA (5 mM), but not by PMSF (10 mM), suggesting that it is a metalloproteinase.
Key words
Snake venom Daboia russelli siamensis Factor X activator MetalloproteinasePreview
Unable to display preview. Download preview PDF.
References
- Amphlett, G. W., Byrne, R., and Castellino, F. J., Cation binding properties of the multiple subforms of RVV-X, the coagulant protein from Vipera russelli. Biochemistry, 21, 125–132 (1982).CrossRefPubMedGoogle Scholar
- Braud, S., Bon, C., and Wisner, A., Snake venom proteins acting on hemostasis. Biochimie, 82, 851–859 (2000).CrossRefPubMedGoogle Scholar
- Farid, T., Nasser, H., Zaki, K., and El-Asmar, M. F., Low molecular weight factor X activator from Cerastes vipera (Sahara sand viper) venom. Toxicon, 31, 1007–1017 (1993).CrossRefPubMedGoogle Scholar
- Farid, T. M., Tu, A. T., and El-Asmar, M. F., Characterization of cerastobin, a thrombin-like enzyme from the venom of Cerastes vipera (Sahara sand viper). Biochemistry, 28, 371–377 (1989).CrossRefPubMedGoogle Scholar
- Franssen, J. H., Janssen-Claessen, T., and Van Dieijen, G., Purification and properties of an activating enzyme of blood clotting factor X from the venom of Cerastes cerastes. Biochim. Biophys. Acta, 747, 186–190 (1983).PubMedGoogle Scholar
- Gowda, D. C., Jackson, C. M., Kurzban, G. P., Mcphie, P., and Davidson, E. A., Core sugar residues of the N-linked oligosaccharides of Russell’s viper venom factor X-activator maintain functionally active polypeptide structure. Biochemistry, 35, 5833–5837 (1996).CrossRefPubMedGoogle Scholar
- Harvey, A. L., Bradley, K. N., Cochran, S. A., Rowan, E. G., Pratt, J. A., Quillfeldt, J. A., and Jerusalinsky, D. A., What can toxins tell us for drug discovery? Toxicon, 36, 1635–1640 (1998).CrossRefPubMedGoogle Scholar
- Hofmann, H. and Bon, C., Blood coagulation induced by the venom of Bothrops atrox. 1. Identification, purification, and properties of a prothrombin activator. Biochemistry, 26, 772–780 (1987).CrossRefPubMedGoogle Scholar
- Kisiel, W., Hermodson, M. A., and Davie, E. W., Factor X activating enzyme from Russell’s viper venom: isolation and characterization. Biochemistry, 15, 4901–4906 (1976).CrossRefPubMedGoogle Scholar
- Koh, D. C., Armugam, A., and Jeyaseelan, K., Snake venom components and their applications in biomedicine. Cell. Mol. Life Sci., 63, 3030–3041 (2006).CrossRefPubMedGoogle Scholar
- Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685 (1970).CrossRefPubMedGoogle Scholar
- Lu, Q., Clemetson, J. M., and Clemetson, K. J., Snake venoms and hemostasis. J. Thromb. Haemost., 3, 1791–1799 (2005).CrossRefPubMedGoogle Scholar
- Marsh, N. A., Snake venoms affecting the haemostatic mechanism-a consideration of their mechanisms, practical applications and biological significance. Blood Coagul. Fibrinolysis, 5, 399–410 (1994).PubMedGoogle Scholar
- Matsui, T., Fujimura, Y., and Titani, K., Snake venom proteases affecting hemostasis and thrombosis. Biochim. Biophys. Acta, 1477, 146–156 (2000).PubMedGoogle Scholar
- Schiffman, S., Theodor, I., and Rapaport, S. I., Separation from Russell’s viper venom of one fraction reacting with factor X and another reacting with factor V. Biochemistry, 8, 1397–1405 (1969).CrossRefPubMedGoogle Scholar
- Sun, H. H., Chen, Q., Lin, X., Chen, J. S., Qiu, P. X., and Yan, G. M., Purification and partial characterizations of coagulant protein FIa from Daboia russelli siamensis (Myanmar) venom. Acta Pharmacol. Sin., 28, 1580–1584 (2007).CrossRefPubMedGoogle Scholar
- Tans, G. and Rosing, J., Snake venom activators of factor X: an overview. Haemostasis, 31, 225–233 (2001).PubMedGoogle Scholar
- Woodhams, B. J., Wilson, S. E., Xin, B. C., and Hutton, R. A., Differences between the venoms of two sub-species of Russell’s viper: Vipera russelli pulchella and Vipera russelli siamensis. Toxicon, 28, 427–433 (1990).CrossRefPubMedGoogle Scholar
- Yamada, D., Sekiya, F., and Morita, T., Prothrombin and factor X activator activities in the venoms of Viperidae snakes. Toxicon, 35, 1581–1589 (1997).CrossRefPubMedGoogle Scholar